Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China
· Delayed Price · Currency is CNY 15.05
+0.12 (0.80%)
Apr 29, 2026, 3:13 PM CST
SHE:300122 Revenue
Chongqing Zhifei Biological Products had revenue of 2.15B CNY in the quarter ending March 31, 2026, a decrease of -9.45%. This brings the company's revenue in the last twelve months to 8.75B, down -48.52% year-over-year. In the year 2025, Chongqing Zhifei Biological Products had annual revenue of 8.96B, down -65.64%.
Revenue (ttm)
8.75B
Revenue Growth
-48.52%
P/S Ratio
4.08
Revenue / Employee
1.21M
Employees
7,220
Market Cap
35.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.96B | -17.11B | -65.64% |
| Dec 31, 2024 | 26.07B | -26.85B | -50.74% |
| Dec 31, 2023 | 52.92B | 14.65B | 38.30% |
| Jan 1, 2023 | 38.26B | 7.61B | 24.83% |
| Dec 31, 2021 | 30.65B | 15.46B | 101.79% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai RAAS Blood Products | 7.35B |
| Hebei Changshan Biochemical Pharmaceutical | 928.01M |
| Shanghai Allist Pharmaceuticals | 5.67B |
| Asymchem Laboratories (Tianjin) | 6.67B |
| Beijing Tiantan Biological Products | 6.17B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 4.32B |
| Suzhou Zelgen Biopharmaceuticals | 810.48M |
| Hualan Biological Engineering | 4.49B |